The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EMB-01, a tetravalent anti-EGFR/cMET bispecific antibody, in the left-sided, RAS/BRAF wild-type, late-line metastatic colorectal cancer: Subgroup analysis of baseline characteristics and response from a phase 1/2 study.
 
Jian Li
No Relationships to Disclose
 
Christine Parseghian
Consulting or Advisory Role - Amgen; Johnson & Johnson/Janssen
Research Funding - BioMed Valley Discoveries; Lilly; Verastem
 
Yanqiao Zhang
No Relationships to Disclose
 
Zhiyu Chen
No Relationships to Disclose
 
Yanru Qin
No Relationships to Disclose
 
Weisheng Zhang
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Changzheng Li
No Relationships to Disclose
 
Fang Ren
No Relationships to Disclose
 
Mingfei Zhang
No Relationships to Disclose
 
Qiaoyang Lu
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Yonghong Zhu
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)